Tech Company Financing Transactions
Metacrine Funding Round
Private investors participated in a $25.6 million capital raise for Metacrine. This venture round was announced on 11/10/2016.
Transaction Overview
Company Name
Announced On
11/10/2016
Transaction Type
Venture Equity
Amount
$25,616,649
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 20 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
3985 Sorrento Valley Blvd. C
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Metacrine (Nasdaq: MTCR) is a biotech company founded in 2015 on technology licensed from the laboratory of Dr. Ronald Evans, a world leader in nuclear hormone receptors and Howard Hughes Medical Institute Investigator at the Salk Institute.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Preston Klassen
Chief Financial Officer
Trisha Millican
Vice President
Nicholas Smith
VP - Operations
Eric Bischoff
Browse more venture capital transactions:
Prev: 11/10/2016: Neuro Kinetics venture capital transaction
Next: 11/10/2016: Telo venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs